Company Filing History:
Years Active: 1989
Title: Peter E Maxim: Innovator in Inflammation Treatment
Introduction
Peter E Maxim is a notable inventor based in Germantown, MD (US). He has made significant contributions to the field of biotechnology, particularly in the treatment of inflammation in mammals. His innovative approach utilizes specific compounds to address both acute and chronic inflammation.
Latest Patents
Peter E Maxim holds a patent for a method of treating inflammation in mammals utilizing ketobutyrolactones. This patent, which is applicable to both acute and chronic inflammation, also discloses the antiviral activity of methylfurylbutyrolactone. His work represents a significant advancement in therapeutic options for inflammation.
Career Highlights
Maxim is associated with the American Biotechnology Company, where he applies his expertise in developing innovative treatments. His work has the potential to impact the lives of many suffering from inflammatory conditions.
Collaborations
One of his notable collaborators is Robert W Veltri, with whom he has worked on various projects related to inflammation treatment.
Conclusion
Peter E Maxim's contributions to the field of biotechnology, particularly in inflammation treatment, highlight his role as an innovative inventor. His work continues to pave the way for new therapeutic approaches.